BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12096963)

  • 1. Postenucleation adjuvant therapy in high-risk retinoblastoma.
    Honavar SG; Singh AD; Shields CL; Meadows AT; Demirci H; Cater J; Shields JA
    Arch Ophthalmol; 2002 Jul; 120(7):923-31. PubMed ID: 12096963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study.
    Kaliki S; Srinivasan V; Gupta A; Mishra DK; Naik MN
    Ophthalmology; 2015 Jun; 122(6):1165-72. PubMed ID: 25841975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
    Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
    Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
    Lee V; Subak-Sharpe I; Hungerford JL; Davies NP; Logani S
    Ophthalmology; 2000 May; 107(5):940-5; discussion 946. PubMed ID: 10811087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
    Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
    J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
    Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
    Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
    Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
    J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining High-risk Retinoblastoma: A Multicenter Global Survey.
    Kaliki S; Shields CL; Cassoux N; Munier FL; Chantada G; Grossniklaus HE; Yoshikawa H; Fabian ID; Berry JL; McKenzie JD; Kimani K; Reddy MA; Parulekar M; Tanabe M; Furuta M; Grigorovski N; Chevez-Barrios P; Scanlan P; Eagle RC; Rashid R; Coronado RD; Sultana S; Staffieri S; Frenkel S; Suzuki S; Ushakova TL; Ji X
    JAMA Ophthalmol; 2022 Jan; 140(1):30-36. PubMed ID: 34762098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic risk factors in retinoblastoma in India.
    Gupta R; Vemuganti GK; Reddy VA; Honavar SG
    Arch Pathol Lab Med; 2009 Aug; 133(8):1210-4. PubMed ID: 19653711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
    Chantada GL; Dunkel IJ; de Dávila MT; Abramson DH
    Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
    Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
    Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
    J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoblastoma with low risk for extraocular relapse.
    Chantada GL; de Dávila MT; Fandiño A; Manzitti J; Raslawski E; Casak S; Schvartzman E
    Ophthalmic Genet; 1999 Sep; 20(3):133-40. PubMed ID: 10520234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of retinoblastoma with vitreous seeds.
    Manjandavida FP; Honavar SG; Reddy VA; Khanna R
    Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.